McCarthy Sean A.
Reporting owner on Forms 3, 4 and 5, CIK 1654058.
McCarthy Sean A. reported on 1 issuer in 1 filing, the latest a Form 4/A filed 2026-10-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CTMX · CytomX Therapeutics, Inc.CIK 1501989 | director, officer (CEO) | 1 | 2026-10-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CTMX · CytomX Therapeutics, Inc.Common Stock | 2025-11-06 | M exercised | +101,793 | $1.59 | 1,191,477 | Form 4/A |
| CTMX · CytomX Therapeutics, Inc.Common Stock | 2025-11-06 | S sold | -101,793 | $4.5377 | 1,089,684 | Form 4/A |
| CTMX · CytomX Therapeutics, Inc.Common Stock, holding | 93,158 | Form 4/A | ||||
| CTMX · CytomX Therapeutics, Inc.Stock Option (Right to Buy), derivative | 2025-11-06 | M exercised | -101,793 | $0 | 348,207 | Form 4/A |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4/A 0001610717-26-000442 | CytomX Therapeutics, Inc. | 2026-10-16 |